Answers are grounded in this paper and cite their sources.
The ability to non-invasively measure neurotransmitter receptors in man by emission computed tomography has the potential to (1) improve understanding of the biochemical basis of neurodegenerative and psychiatric disorders; (2) monitor drug action by directly measuring changes in receptor occupancy; and (3) lead to improved knowledge of the physiology of neurotransmitter systems by monitoring changes in receptor occupancy as a result of altered neurotransmitter release. James Frost describes selective ligands currenly available to image neuroreceptors and their subtypes and their use in elucidating biochemical events in health and disease.
No takes yet. Share an insight, caveat, or question.
J. James Frost (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: